|
▽
|
IRWD |
Ironwood Pharmaceuticals, Inc. |
Healthcare |
4.5 |
|
|
None |
|
-0.7 |
-1.9 |
-6.3 |
289.4 |
-4.12 |
-226.4 |
0.84 |
|
-73.51 |
|
2024-11-02 |
| Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment |
|
▽
|
ISRG |
Intuitive Surgical, Inc. |
Healthcare |
41.7 |
|
|
None |
|
100.3 |
13.6 |
5.0 |
13.5 |
-14.85 |
25.2 |
4.76 |
4.02 |
86.18 |
|
2024-11-02 |
| Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care. The company offers the da Vinci Surgical System that enables complex surgery |
|
▽
|
IT |
Gartner, Inc. |
Technology |
24.9 |
0.0 |
|
0 |
0.0 |
44.0 |
57.0 |
11.5 |
|
-11.42 |
14.9 |
0.91 |
|
8.69 |
7 |
2024-11-02 |
| Gartner, Inc. operates as a research and advisory company in the United States, Canada, Europe, the Middle East, Africa, and internationally. It operates through three segments: Research, Conferences, and Consulting. The Research |
|
▽
|
ITCI |
Intra-Cellular Therapies Inc. |
Healthcare |
44.5 |
|
|
None |
|
-65.7 |
15.5 |
-1.3 |
-23.6 |
-61.91 |
-30.2 |
5.41 |
5.31 |
81.21 |
|
2024-11-02 |
| Intra-Cellular Therapies, Inc. focuses on the discovery, clinical development, and commercialization of small molecule drugs. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also |
|
▽
|
ITGR |
Integer Holdings Corporation |
Healthcare |
11.2 |
|
|
None |
|
46.8 |
2.8 |
2.7 |
|
-12.39 |
5.7 |
2.80 |
1.71 |
51.62 |
|
2024-11-02 |
| Integer Holdings Corporation operates as a medical device outsource manufacturer. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, |
|
▽
|
ITOS |
iTeos Therapeutics, Inc. |
Healthcare |
-19.8 |
|
|
None |
|
-2.9 |
0.6 |
-3.1 |
-19.6 |
651.24 |
|
13.76 |
|
86.17 |
|
2024-11-02 |
| Iteos Therapeutics, Inc. engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, is in Phase 1b |
|
▽
|
ITRI |
Itron, Inc. |
Technology |
27.6 |
|
|
None |
|
51.9 |
3.8 |
2.2 |
|
0.88 |
4.5 |
1.95 |
1.43 |
50.34 |
|
2024-11-02 |
| Itron, Inc. provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers |
|
▽
|
ITT |
ITT Inc. |
Industrials |
16.6 |
1.0 |
9.9 |
21 |
23.0 |
27.9 |
4.5 |
5.0 |
16.2 |
-8.95 |
12.5 |
1.79 |
1.24 |
64.29 |
2, 3, 5, 6, 8, 9, 11, 12 |
2024-11-02 |
| ITT Inc. manufactures and sells engineered critical components and customized technology solutions. The Motion Technologies segment manufactures brake pads, shims, shock absorbers, and energy absorption components. The Industrial Process segment provides industrial pumps, valves, and plant |
|
▽
|
ITW |
Illinois Tool Works Inc. |
Industrials |
15.5 |
2.1 |
14.9 |
28 |
54.1 |
26.3 |
25.8 |
10.0 |
|
-7.79 |
18.4 |
1.33 |
0.97 |
19.41 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 |
2024-11-02 |
| Illinois Tool Works Inc. manufactures and sells industrial products and equipment in the United States and internationally. It operates through seven segments. The company offers Automotive OEM, Food Equipment, Test & Measurement and Electronics, Welding, Poly |
|
▽
|
IVR |
INVESCO MORTGAGE CAPITAL INC |
Real Estate |
-2.6 |
29.0 |
8.2 |
0 |
|
-27.9 |
0.6 |
-0.3 |
-2.0 |
-2227.18 |
-378.3 |
|
|
14.81 |
1, 3, 4, 5, 6, 7, 9, 10, 12 |
2024-11-02 |
| Invesco Mortgage Capital Inc. invests, finances, and manages mortgage-backed securities and other mortgage-related assets in the United States. It has elected to be taxed as a REIT and would be subject to federal corporate income taxes |